KLK15 is a new potential independent marker for unfavorable prognosis in ovarian cancer.

被引：0
|
作者：
Yousef, GM
Scorilas, A
Fracchioli, S
Iskander, L
Raouf, AA
Massobrio, M
Katsaros, D
Diamandis, EP
机构：
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Natl Ctr Sci Res, Athens, Greece
[3] Univ Turin, Turin, Italy
[4] Univ Toronto, Toronto, ON, Canada
[5] Menoufia Univ, Shibin Al Kawm, Egypt
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
D118
引用
收藏
页码：A148 / A148
页数：1
相关论文
共 50 条
  • [41] Epigenetic Marker and Susceptibility and Prognosis of Epithelial Ovarian Cancer
    Maduro, Maria Rosa
    REPRODUCTIVE SCIENCES, 2016, 23 (01) : 5 - 5
  • [42] High PD-L2 Protein Expression in Cancer Cells is an Independent Marker of Unfavorable Prognosis in Luminal Breast Tumors
    Chaudhary, Lubna N.
    Chervoneva, Inna
    Peck, Amy R.
    Sun, Yunguang
    Yi, Misung
    Langenheim, John F.
    Jorns, Julie M.
    Kamaraju, Sailaja
    Cheng, Yee Chung
    Burfeind, John
    Chitambar, Christopher R.
    Hooke, Jeffrey A.
    Kovatich, Albert J.
    Shriver, Craig
    Hu, Hai
    Palazzo, Juan P.
    Bibbo, Marluce
    Hyslop, Terry
    Pestell, Richard
    Mitchell, Edith P.
    Rui, Hallgeir
    CANCER RESEARCH, 2023, 83 (05)
  • [43] High expression of Cyclin D1 is an independent marker for favorable prognosis in Middle Eastern breast cancer.
    Al-Kuraya, Khawla S.
    Siraj, Abdul K.
    Parvathareddy, Sandeep K.
    Siraj, Sarah
    Azam, Saud
    Annaiyappanaidu, Padmanaban
    Sabido, Maria Angelita
    Diaz, Mark Ranier
    CANCER RESEARCH, 2021, 81 (13)
  • [44] New diagnostic markers for ovarian cancer.
    Kuo, WL
    Lapuk, A
    Gray, J
    Fishman, D
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 155A - 155A
  • [45] Potential Targets for Immunotherapy in Epithelial Ovarian Cancer.
    Daudi, Sayeema
    Miliotto, Tony
    Groman, Adrienne
    Lele, Shashikant
    Odunsi, Kunle
    REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 312A - 312A
  • [46] Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer
    Theriault, Brigitte L.
    Pajovic, Sanja
    Bernardini, Marcus Q.
    Shaw, Patricia A.
    Gallie, Brenda L.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (08) : 1844 - 1854
  • [47] Neural activities are unfavorable for the prognosis of ovarian cancer through mRNA expression analysis
    Yang, Lili
    Bie, Li
    Sun, Liqun
    Yue, Ying
    BIOMARKERS IN MEDICINE, 2019, 13 (08) : 663 - 674
  • [48] MUC1 MARKER FOR THE DETECTION OF OVARIAN CANCER. A REVIEW
    Florea, Anca
    Cristea, Cecilia
    Sandulescu, Robert
    FARMACIA, 2014, 62 (01) : 1 - 13
  • [49] Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers
    Dong, Y
    Kaushal, A
    Brattsand, M
    Nicklin, J
    Clements, JA
    CLINICAL CANCER RESEARCH, 2003, 9 (05) : 1710 - 1720
  • [50] Human tissue kallikrein 7 over-expression in ovarian carcinoma: a novel marker of unfavorable prognosis
    Shan, Shannon J. C.
    Scorilas, Andreas
    Soosaipillai, Antoninus
    Katsaros, Dionyssios
    Rigault, Irene
    Puopolo, Manuela
    Diamandis, Eleftherios P.
    CANCER RESEARCH, 2006, 66 (08)
12345